Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00722059 · ClinicalTrials.gov registry record · Early Phase 1
Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography
A Early Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 50
- Enrollment target
NCT00722059 is a Early Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 50 participants.
The verdict
NCT00722059, a Early Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to compare 3D mammography with digital mammography in women with dense breasts for the detection and evaluation of masses and/or breast cancer.
Interventions
- PROCEDURE Breast Tomosynthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-04 |
| Est. Completion | 2013-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00722059
The ClinicalTrials.gov registry entry for NCT00722059 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breast Tomosynthesis is the first listed.
NCT00722059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00722059 about?
NCT00722059 is a clinical study titled "Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography". The purpose of this study is to compare 3D mammography with digital mammography in women with dense breasts for the detection and evaluation of masses and/or breast cancer.
What is the current status of trial NCT00722059?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2006-04. Estimated completion is 2013-10.
What interventions are being tested in trial NCT00722059?
The interventions under investigation include: Breast Tomosynthesis (PROCEDURE).
Who is sponsoring clinical trial NCT00722059?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.